Patents Assigned to ProDeg, LLC
  • Patent number: 11691945
    Abstract: The invention relates to compounds that inhibit DUBs, particularly USP9X. The invention also includes methods of inhibiting DUBs, including USP9X, and methods of treating cancers.
    Type: Grant
    Filed: November 16, 2022
    Date of Patent: July 4, 2023
    Assignee: ProDeg, LLC
    Inventors: Richard Martinelli, Julian F. Bond